Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel silver-catalyzed oxidative cyclization for high-purity imidazo[1,2-a]pyridine. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN106518839A enables safe 2-thiopheneacetic acid production. High purity pharmaceutical intermediates with reduced toxic waste and scalable manufacturing processes.
Patent CN102850314B enables aqueous ionic liquid catalysis for benzoxanthene derivatives ensuring high purity and scalable environmentally friendly manufacturing processes for global supply chains.
Patent CN110092753B reveals a high-yield 4-step synthesis for 3-azabicyclo[4.1.0]heptane-2-carboxylic acid, offering significant cost reduction and scalable supply chain solutions.
Patent CN107151246B reveals cost-effective chiral resolution. Reliable supplier for high-purity levo-praziquantel intermediates with scalable processes.
Novel sulfonamide route for 2-chloro-6-bromoaniline. High yield, mild conditions, cost-effective manufacturing for global supply chains and procurement.
Advanced 5-step synthesis of FTY720 intermediate via patent CN1814583A. Offers significant cost reduction and high purity for immunosuppressant manufacturing.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN102391169B offers high-purity BPH intermediate synthesis. Ether solvent method ensures safety and scalability for pharmaceutical supply chains.
Novel Heck reaction synthesis for Ramelteon intermediate offers high yield and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Advanced anhydrous synthesis of Aripiprazole Lauroxil via paraformaldehyde. Delivers high-purity antipsychotic prodrugs with improved yields and cost reduction in API manufacturing.
Patent CN110396072B details a cost-effective dual-catalyst route for (S)-3-hydroxytetrahydrofuran, offering high optical purity and scalable manufacturing for global pharmaceutical supply chains.
Novel photocatalytic CO2 fixation method offers high-purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Patent CN116768938B reveals iron catalyst technology for Rimegepant intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN103880790A details a green Pd-catalyzed oxidative coupling for bifurans. This method offers significant cost reduction in pharmaceutical manufacturing and superior scalability.
Patent CN112979563B details a recyclable ionic liquid method for high-purity pharmaceutical intermediates, offering significant cost reduction and simplified purification for global supply chains.
Novel 4-step metal-free synthesis of Fevipiprant intermediate. Reduces cost and improves purity for asthma drug manufacturing via patent CN108484595B.
Novel patent CN106588932B offers high-yield tenofovir intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers globally.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.
Patent CN108069860B details a high-yield Lewis acid-catalyzed bromination route for o-nitrobenzyl bromide, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain stability.